Goldline Pharmaceutical Ltd (544759) — Insider Trading | 29 August 2026(2 announcements)

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Insider Trading 🔴 High Importance Neutral 📄 PDF
2 Insider Trading 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Promoter Swapan Khandelwal acquired 78,000 shares
🔄 What Changed
Holding increased to 0.81% of total shares
💡 Investor Takeaway
The promoter's purchase signals confidence in the company's valuation at current levels.

Goldline Pharmaceutical disclosed that promoter and Whole Time Director Mr. Swapan Khandelwal acquired 78,000 shares at [amount not verified]each, increasing his holding to 0.81% of total issued shares as of 28 August 2026, per SEBI SAST Regulation 29(2).

About Goldline Pharmaceutical Ltd (544759)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹38.4 Cr

View full 544759 stock details →

📡 Get AI alerts when 544759 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544759 — Free

📊 More 544759 filings

See all 544759 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day